Research
Ovarian cancer action is dedicated to advancing and supporting ovarian cancer research as part of its mission to save women's lives.
We are an independent charity and fund a broad range of research to achieve:
accurate and early detection
more effective treatments
prevention
The Ovarian cancer action Research Centre at Imperial College London is the only UK research facility entirely dedicated to ovarian cancer. Under Professor Hani Gabra's leadership, we aim to build the centre into an international hub for ovarian cancer research, fast-tracking new treatments from bench to bedside. Click here for further information about the pioneering work underway at the Ovarian cancer action Research Centre.
In addition to funding research within our Research Centre, we also invite applications for funding from other UK research institutions – hospitals and universities. We currently fund ground-breaking research projects at University College London and at Barts and The London. Click here for further information about applying to Ovarian cancer action for a research grant.
We also organise a series of international conferences to exchange knowledge, to identify new avenues for research and to foster collaboration. The OCA/HHMT International Forum alternates with the OCA International Conference
All of the research that we fund is subject to rigorous peer review – the gold standard for medical research funding – to ensure that we fund only the most promising ovarian cancer research. The Medical Science Review Committee is chaired by Dr Robert Bast, Vice-President, Translational Research, University of Texas M.D. Anderson Cancer Centre, USA and comprises many of the world's leading ovarian cancer research specialists.
Ovarian cancer action is a member of the Association of Medical Research Charities – a membership organisation of the leading medical health and research charities in the UK 